QQQ   271.52 (+2.39%)
AAPL   450.76 (+3.03%)
MSFT   208.86 (+2.69%)
FB   260.05 (+1.53%)
GOOGL   1,503.00 (+1.52%)
AMZN   3,151.84 (+2.31%)
NVDA   454.09 (+4.63%)
CGC   17.37 (+2.48%)
BABA   254.86 (+2.59%)
TSLA   1,512.74 (+10.07%)
GE   6.63 (-1.49%)
MU   48.36 (+1.26%)
AMD   81.85 (+6.46%)
T   30.14 (-0.20%)
F   7.12 (-1.52%)
ACB   9.92 (-1.00%)
GILD   68.77 (+0.98%)
NFLX   478.75 (+2.53%)
DIS   131.09 (+0.46%)
BAC   26.56 (-1.34%)
BA   176.20 (-2.18%)
QQQ   271.52 (+2.39%)
AAPL   450.76 (+3.03%)
MSFT   208.86 (+2.69%)
FB   260.05 (+1.53%)
GOOGL   1,503.00 (+1.52%)
AMZN   3,151.84 (+2.31%)
NVDA   454.09 (+4.63%)
CGC   17.37 (+2.48%)
BABA   254.86 (+2.59%)
TSLA   1,512.74 (+10.07%)
GE   6.63 (-1.49%)
MU   48.36 (+1.26%)
AMD   81.85 (+6.46%)
T   30.14 (-0.20%)
F   7.12 (-1.52%)
ACB   9.92 (-1.00%)
GILD   68.77 (+0.98%)
NFLX   478.75 (+2.53%)
DIS   131.09 (+0.46%)
BAC   26.56 (-1.34%)
BA   176.20 (-2.18%)
QQQ   271.52 (+2.39%)
AAPL   450.76 (+3.03%)
MSFT   208.86 (+2.69%)
FB   260.05 (+1.53%)
GOOGL   1,503.00 (+1.52%)
AMZN   3,151.84 (+2.31%)
NVDA   454.09 (+4.63%)
CGC   17.37 (+2.48%)
BABA   254.86 (+2.59%)
TSLA   1,512.74 (+10.07%)
GE   6.63 (-1.49%)
MU   48.36 (+1.26%)
AMD   81.85 (+6.46%)
T   30.14 (-0.20%)
F   7.12 (-1.52%)
ACB   9.92 (-1.00%)
GILD   68.77 (+0.98%)
NFLX   478.75 (+2.53%)
DIS   131.09 (+0.46%)
BAC   26.56 (-1.34%)
BA   176.20 (-2.18%)
QQQ   271.52 (+2.39%)
AAPL   450.76 (+3.03%)
MSFT   208.86 (+2.69%)
FB   260.05 (+1.53%)
GOOGL   1,503.00 (+1.52%)
AMZN   3,151.84 (+2.31%)
NVDA   454.09 (+4.63%)
CGC   17.37 (+2.48%)
BABA   254.86 (+2.59%)
TSLA   1,512.74 (+10.07%)
GE   6.63 (-1.49%)
MU   48.36 (+1.26%)
AMD   81.85 (+6.46%)
T   30.14 (-0.20%)
F   7.12 (-1.52%)
ACB   9.92 (-1.00%)
GILD   68.77 (+0.98%)
NFLX   478.75 (+2.53%)
DIS   131.09 (+0.46%)
BAC   26.56 (-1.34%)
BA   176.20 (-2.18%)
Log in

NASDAQ:BRKRBruker Stock Price, Forecast & News

$44.22
+0.58 (+1.33 %)
(As of 08/12/2020 01:18 PM ET)
Add
Compare
Today's Range
$43.88
Now: $44.22
$44.27
50-Day Range
$37.96
MA: $41.84
$46.17
52-Week Range
$30.78
Now: $44.22
$54.49
Volume3,384 shs
Average Volume553,498 shs
Market Capitalization$6.82 billion
P/E Ratio41.72
Dividend Yield0.36%
Beta1.39
Bruker Corporation manufactures and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates in two segments, Bruker Scientific Instruments, and Bruker Energy & Supercon Technologies. It offers life science tools based on magnetic resonance technology; life science mass spectrometry and ion mobility spectrometry solutions; infrared spectroscopy and radiological/nuclear detectors for chemical, biological, radiological, nuclear, and explosive detection in emergency response, homeland security, and defense applications; and research, analytical, and process analysis instruments and solutions based on infrared and Raman molecular spectroscopy technologies. The company also provides X-ray instruments, atomic force microscopy instrumentation, fluorescence optical microscopy instruments, analytical tools for electron microscopes and X-ray metrology, defect-detection equipment for semiconductor process control, and spark optical emission spectroscopy systems, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments. In addition, it offers superconducting and non-superconducting materials and devices. The company serves pharmaceutical, biotechnology, and diagnostics companies; chemical, food and beverage, clinical, and polymer companies; nonprofit laboratories; contract research organizations, academic institutions, medical schools, nonprofit or for-profit forensics, environmental and clinical microbiology laboratories, and hospitals and government departments and agencies, as well as agriculture, and food and beverage safety companies; nanotechnology, semiconductor, and industrial companies; and raw material manufacturers and other businesses through direct sales forces, distributors, independent sales representatives, and other representatives. Bruker Corporation was incorporated in 1991 and is headquartered in Billerica, Massachusetts.
Read More
Bruker logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.2Community Rank: 2.4Dividend Strength: 1.7Insider Behavior: 1.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.49 out of 5 stars


Industry, Sector and Symbol

Industry Analytical instruments
Sub-IndustryLife Sciences Tools & Services
Current SymbolNASDAQ:BRKR
CUSIP11679410
Phone978-663-3660

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.07 billion
Cash Flow$2.08 per share
Book Value$5.88 per share

Profitability

Net Income$197.20 million

Miscellaneous

Employees7,230
Market Cap$6.82 billion
Next Earnings Date10/29/2020 (Estimated)
OptionableOptionable
$44.22
+0.58 (+1.33 %)
(As of 08/12/2020 01:18 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive BRKR News and Ratings via Email

Sign-up to receive the latest news and ratings for BRKR and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Bruker (NASDAQ:BRKR) Frequently Asked Questions

How has Bruker's stock been impacted by COVID-19 (Coronavirus)?

Bruker's stock was trading at $40.00 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, BRKR shares have increased by 10.6% and is now trading at $44.22.
View which stocks have been most impacted by Coronavirus
.

Do Wall Street analysts recommend investors buy shares of Bruker?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Bruker in the last year. There are currently 1 sell rating, 5 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Bruker
.

When is Bruker's next earnings date?

Bruker is scheduled to release its next quarterly earnings announcement on Thursday, October 29th 2020.
View our earnings forecast for Bruker
.

How were Bruker's earnings last quarter?

Bruker Co. (NASDAQ:BRKR) announced its quarterly earnings results on Monday, August, 3rd. The medical research company reported $0.21 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.05 by $0.16. The medical research company earned $424.60 million during the quarter, compared to analyst estimates of $395.51 million. Bruker had a net margin of 8.35% and a return on equity of 22.70%. Bruker's quarterly revenue was down 13.4% on a year-over-year basis. During the same period last year, the business posted $0.33 EPS.
View Bruker's earnings history
.

How often does Bruker pay dividends? What is the dividend yield for Bruker?

Bruker announced a quarterly dividend on Friday, August 7th. Stockholders of record on Tuesday, September 1st will be given a dividend of $0.04 per share on Friday, September 18th. This represents a $0.16 dividend on an annualized basis and a yield of 0.36%. The ex-dividend date is Monday, August 31st.
View Bruker's dividend history
.

What guidance has Bruker issued on next quarter's earnings?

Bruker updated its second quarter 2020 Pre-Market earnings guidance on Wednesday, July, 22nd. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $420-425 million, compared to the consensus revenue estimate of $388.84 million.

What price target have analysts set for BRKR?

10 equities research analysts have issued 1-year price targets for Bruker's stock. Their forecasts range from $27.00 to $63.00. On average, they anticipate Bruker's stock price to reach $44.95 in the next twelve months. This suggests a possible upside of 1.7% from the stock's current price.
View analysts' price targets for Bruker
.

Has Bruker been receiving favorable news coverage?

News articles about BRKR stock have been trending negative recently, according to InfoTrie. The research firm ranks the sentiment of media coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Bruker earned a news sentiment score of -2.2 on InfoTrie's scale. They also assigned news stories about the medical research company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the company's share price in the near term.
View the latest news about Bruker
.

Are investors shorting Bruker?

Bruker saw a increase in short interest in February. As of February 15th, there was short interest totaling 2,910,000 shares, an increase of 18.8% from the January 31st total of 2,450,000 shares. Based on an average daily volume of 557,900 shares, the days-to-cover ratio is presently 5.2 days. Currently, 2.8% of the shares of the company are short sold.
View Bruker's Short Interest
.

Who are some of Bruker's key competitors?

What other stocks do shareholders of Bruker own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Bruker investors own include AbbVie (ABBV), Cisco Systems (CSCO), CVS Health (CVS), Micron Technology (MU), Alibaba Group (BABA), Intel (INTC), Walt Disney (DIS), Applied Materials (AMAT), Bank of America (BAC) and Bristol-Myers Squibb (BMY).

Who are Bruker's key executives?

Bruker's management team includes the following people:
  • Dr. Frank H. Laukien, Chairman, CEO & Pres (Age 59)
  • Mr. Gerald N. Herman, CFO, VP & Corp. Controller (Age 61)
  • Dr. Mark R. Munch, Exec. VP and Pres of Bruker Nano Group & Bruker Nano Surfaces Division (Age 57)
  • Mr. Juergen Srega, Pres of Bruker CALID Group & Bruker Daltonics Division (Age 64)
  • Dr. Falko Busse, Exec. Officer (Age 52)

What is Bruker's stock symbol?

Bruker trades on the NASDAQ under the ticker symbol "BRKR."

Who are Bruker's major shareholders?

Bruker's stock is owned by many different institutional and retail investors. Top institutional shareholders include GWM Advisors LLC (0.45%), Palisade Capital Management LLC NJ (0.39%), Boston Trust Walden Corp (0.37%), Ceredex Value Advisors LLC (0.29%), Great Lakes Advisors LLC (0.25%) and Russell Investments Group Ltd. (0.18%). Company insiders that own Bruker stock include Burkhard Prause, Cynthia M Friend, Frank H Laukien, Marc A Kastner and Mark Munch.
View institutional ownership trends for Bruker
.

Which institutional investors are selling Bruker stock?

BRKR stock was sold by a variety of institutional investors in the last quarter, including GWM Advisors LLC, First Trust Advisors LP, NN Investment Partners Holdings N.V., Mackay Shields LLC, Russell Investments Group Ltd., NN Investment Partners Holdings N.V., MERIAN GLOBAL INVESTORS UK Ltd, and CWM LLC. Company insiders that have sold Bruker company stock in the last year include Burkhard Prause, Cynthia M Friend, Marc A Kastner, and Mark Munch.
View insider buying and selling activity for Bruker
.

Which institutional investors are buying Bruker stock?

BRKR stock was bought by a variety of institutional investors in the last quarter, including Bank of Nova Scotia, DekaBank Deutsche Girozentrale, Boston Trust Walden Corp, Ceredex Value Advisors LLC, Swiss National Bank, WINTON GROUP Ltd, Great Lakes Advisors LLC, and Cambiar Investors LLC.
View insider buying and selling activity for Bruker
.

How do I buy shares of Bruker?

Shares of BRKR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Bruker's stock price today?

One share of BRKR stock can currently be purchased for approximately $44.22.

How big of a company is Bruker?

Bruker has a market capitalization of $6.82 billion and generates $2.07 billion in revenue each year. The medical research company earns $197.20 million in net income (profit) each year or $1.57 on an earnings per share basis. Bruker employs 7,230 workers across the globe.

What is Bruker's official website?

The official website for Bruker is www.bruker.com.

How can I contact Bruker?

Bruker's mailing address is 40 Manning Road, Billerica MA, 01821. The medical research company can be reached via phone at 978-663-3660 or via email at [email protected]

This page was last updated on 8/12/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.